Vivian Quinn is experienced in all aspects of civil litigation with primary emphasis on managing national and regional engagements. She has exceptional case management skills, and provides critical coordination and communication on complex matters.
I devote a significant amount of time defending food, pharma and medical device companies as well as counseling clients regarding safety and regulatory compliance. My background in mathematics, science, psychology and law combine to provide clients with the best possible representation in matters related to these fields.
I have been following developments regarding economic damage class actions (primarily in the food industry) and will be helping clients fine tune defense strategies in this arena.
Vivian is a member of the Defense Research Institute’s (DRI) Drug and Medical Device Steering Committee and serves on several editorial boards for law and strategy publications. She has also contributed to numerous publications, including Rx for the Defense, the newsletter of the DRI Drug and Medical Device Committee (editor and contributor); Consumer Product Safety Primer: An Introductory Guide to the Regulatory System; and State Surveys of Products Liability and Toxic Tort Law.
As Nixon Peabody’s Litigation Department Resource Partner, she leads team efforts and ensures projects are staffed with the right resources and with strong commitment and communication throughout the process.
Law360 | May 27, 2021
This article covers a court’s unanimous refusal to revive litigation claiming that client SPX Corp. contaminated Wisconsin properties, with the panel noting a lower court was correct to find the requested injunctive relief improper. Buffalo partner Vivian Quinn, Long Island partner Joe Ortego, and Buffalo counsel Laurie Bloom and Tracey Scarpello, all of the Complex Commercial Disputes group, led the successful defense of SPX.
Law360 | June 25, 2020
This article, covering a federal judge’s dismissal of claims against NP client Bayer Corp. related to the company’s Essure birth control device, mentions Buffalo Complex Commercial Disputes partner Vivian Quinn and counsel Tracey Scarpello for representing Bayer.
Defense Research Institute | September 04, 2019
Complex Commercial Disputes partner Vivian Quinn and associate Tracey Scarpello, both of the Buffalo office, co-wrote this article in the Defense Research Institute’s publication, analyzing the impact of the ascertainability requirement on pharmaceutical and medical device class actions.
Food, Beverage & Agribusiness Alert | 04.17.20
Food, Beverage & Agriculture Alert | 12.20.18
New York University, J.D.
Columbia University, M.A.
University of Notre Dame, B.S.
U.S. Court of Appeals, Second Circuit
U.S. District Court, Eastern District of New York
U.S. District Court, Northern District of New York
U.S. District Court, Southern District of New York
U.S. District Court, Western District of New York
Vivian was selected, through a peer-review survey, for inclusion in The Best Lawyers in America© 2021 in the fields of Mass Tort Litigation/Class Actions—Defendants and Product Liability Litigation—Defendants. She has been listed in Best Lawyers since 2014. Vivian was named Best Lawyers® 2021 Mass Tort Litigation / Class Actions - Defendants “Lawyer of the Year” in Buffalo.
Vivian has also been recognized by The Legal 500 (2013–present) in the area of Dispute resolution—Product liability, mass tort and class action—Defense; by International Who’s Who of Life Sciences Lawyers (2012–present); and by LMG Life Sciences (2013–present) as a “Life Sciences Star.”
Vivian is a court-appointed mediator for the United States District Court for the Western District of New York and serves on the Editorial Board of LJN Product Liability Law & Strategy. She is a member of the Defense Research Institute (DRI) Drug and Medical Device Committee (serving on the Steering Committee), the American, New York State and Erie County bar associations, the Western New York Defense Trial Lawyers Association, and the Board of Directors for Buffalo Prep.